These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 9834944)

  • 41. Formulation design and optimization of modified-release microspheres of diclofenac sodium.
    Gohel MC; Amin AF
    Drug Dev Ind Pharm; 1999 Feb; 25(2):247-51. PubMed ID: 10065360
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cataplasm-based controlled drug delivery: development and optimization of a novel formulation.
    Agarwal V; Singh SK; Reddy IK; Durrani MJ; Khan MA
    Drug Dev Ind Pharm; 1999 May; 25(5):659-65. PubMed ID: 10219536
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Response surface methodology to investigate the iontophoretic delivery of tacrine hydrochloride.
    Upasani RS; Banga AK
    Pharm Res; 2004 Dec; 21(12):2293-9. PubMed ID: 15648261
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development and optimization of osmotically controlled asymmetric membrane capsules for delivery of solid dispersion of lycopene.
    Jain N; Sareen R; Mahindroo N; Dhar KL
    ScientificWorldJournal; 2014; 2014():438528. PubMed ID: 24605053
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Formulation Optimization of Zuojin Floating-Bioadhesive Pellets by Central Composite Design-Response Surface Methodology].
    Xu F; Wang LL; Shi ZQ; Chen F; Sun DM
    Zhong Yao Cai; 2015 Sep; 38(9):1969-73. PubMed ID: 26930991
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Formulation and stability evaluation of extemporaneously prepared atenolol capsules from crushed atenolol tablets.
    Zaid AN; Malkieh N; Kharoaf M; Abu Ghoush A; Al-Ramahi R
    Int J Pharm Compd; 2012; 16(4):342-6. PubMed ID: 23050394
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel cyclodextrin-based film formulation intended for buccal delivery of atenolol.
    Jug M; Bećirević-Laćan M; Bengez S
    Drug Dev Ind Pharm; 2009 Jul; 35(7):796-807. PubMed ID: 19259876
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Optimization of cataplasm matrix with face-centered design-response surface method].
    Liu S; Li J; Jin R; Du M
    Zhongguo Zhong Yao Za Zhi; 2009 Dec; 34(24):3211-3. PubMed ID: 20353002
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Application of multiple response optimization technique to extended release formulations design.
    Hamed E; Sakr A
    J Control Release; 2001 Jun; 73(2-3):329-38. PubMed ID: 11516509
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative in vitro diffusion studies for atenolol transdermal delivery system.
    Demou JS; Sidhom MB; Plakogiannis FM
    Pharm Acta Helv; 1994 May; 68(4):215-9. PubMed ID: 8208745
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Optimization of Paclitaxel Containing pH-Sensitive Liposomes By 3 Factor, 3 Level Box-Behnken Design.
    Rane S; Prabhakar B
    Indian J Pharm Sci; 2013 Jul; 75(4):420-6. PubMed ID: 24302796
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combined mixture-process variable approach: a suitable statistical tool for nanovesicular systems optimization.
    Habib BA; AbouGhaly MH
    Expert Opin Drug Deliv; 2016 Jun; 13(6):777-88. PubMed ID: 27020331
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design, Characterization, and Optimization of Controlled Drug Delivery System Containing Antibiotic Drug/s.
    Patel A; Dodiya H; Shelate P; Shastri D; Dave D
    J Drug Deliv; 2016; 2016():9024173. PubMed ID: 27610247
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of polysorbates on atenolol release from film-coated tablets.
    Mohammadi Samani S; Adrangui M; Farid DJ; Nokhodchi A
    Drug Dev Ind Pharm; 1999 Apr; 25(4):513-6. PubMed ID: 10194606
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Formulation of topical bioadhesive gel of aceclofenac using 3-level factorial design.
    Singh S; Parhi R; Garg A
    Iran J Pharm Res; 2011; 10(3):435-45. PubMed ID: 24250375
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Formulation of a dry powder influenza vaccine for nasal delivery.
    Garmise RJ; Mar K; Crowder TM; Hwang CR; Ferriter M; Huang J; Mikszta JA; Sullivan VJ; Hickey AJ
    AAPS PharmSciTech; 2006 Mar; 7(1):E19. PubMed ID: 16584149
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aqueous-based polymeric dispersion: face-centered cubic design for the development of atenolol gastrointestinal therapeutic system.
    Sastry SV; Khan MA
    Pharm Dev Technol; 1998 Nov; 3(4):423-32. PubMed ID: 9834944
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aqueous based polymeric dispersion: Plackett--Burman design for screening of formulation variables of atenolol gastrointestinal therapeutic system.
    Sastry SV; Khan MA
    Pharm Acta Helv; 1998 Jul; 73(2):105-12. PubMed ID: 9700939
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-term stability characterization of a controlled release gastrointestinal therapeutic system coated with a cellulose acetate pseudolatex.
    Vaithiyalingam SR; Sastry SV; Dehon RH; Reddy IK; Khan MA
    Pharmazie; 2001 Jan; 56(1):66-9. PubMed ID: 11210674
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Formulation and optimization of controlled release mucoadhesive tablets of atenolol using response surface methodology.
    Singh B; Chakkal SK; Ahuja N
    AAPS PharmSciTech; 2006 Jan; 7(1):E3. PubMed ID: 16584161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.